Stocks making the biggest moves midday: Etsy, EchoStar, Robinhood, Canada Goose & more

Robinhood and AppLovin surged 14% and 10% respectively on news of their upcoming inclusion in the S&P 500 index, effective September 22, which is expected to drive buying from passive funds. EchoStar also gained 14% after agreeing to sell spectrum licenses to SpaceX for up to $17 billion. Conversely, Summit Therapeutics plunged 25% following disappointing Phase 3 trial results for its lung cancer drug in European and North American patients, while gold miners saw gains after reports indicated Tether is exploring investments in the gold mining sector.

Analysis

Significant market movements are being driven by index rebalancing, strategic corporate actions, and clinical trial results. Robinhood (HOOD) and AppLovin (APP) surged 14% and 10% respectively following S&P Global's announcement of their inclusion in the S&P 500, a technical event that will force buying from passive index funds ahead of the Sept. 22 effective date. Similarly, Nutanix (NTNX) and TransUnion (TRU) climbed 8% and 3% on their addition to the S&P MidCap 400. In corporate transactions, EchoStar (SATS) gained 14% after agreeing to sell spectrum licenses to SpaceX for up to $17 billion, a deal that sent shares of competing telecoms T-Mobile, AT&T, and Verizon down by at least 1.7%. The biotechnology sector saw extreme volatility, with Summit Therapeutics (SMMT) plunging 25% after its lung cancer drug, ivonescimab, showed disappointing Phase 3 trial results in European and North American patients compared to Chinese patients. Conversely, analyst upgrades provided positive catalysts, with Canada Goose (GOOS) rising 14% on a TD Cowen 'buy' rating citing brand modernization, and Veeva Systems (VEEV) adding 2% on a JPMorgan 'overweight' rating. Elsewhere, gold miners such as Hecla Mining (+12%) and Harmony Gold (+3%) advanced on reports that stablecoin giant Tether is exploring investments in the gold mining supply chain, suggesting a potential new source of capital for the sector.

Key Decisions for Investors

• The surge in Robinhood and AppLovin is primarily driven by a short-term technical catalyst of index inclusion, so investors should consider the risk of a price correction after passive funds complete their mandatory purchases around September 22.
• The 25% collapse of Summit Therapeutics on geographically-dependent trial data underscores the binary risk in biopharmaceutical stocks; investors should scrutinize the global applicability of clinical trial results before investing.
• EchoStar's $17 billion spectrum sale to SpaceX represents a major competitive shift in the telecommunications sector, warranting a review of positions in incumbent players like T-Mobile, AT&T, and Verizon, which are now facing a better-capitalized challenger.
• Reported interest from Tether in the gold mining sector could be a significant long-term catalyst, so investors might consider monitoring gold miners like Hecla Mining for confirmation of this new capital inflow.
• The positive stock reactions to analyst upgrades for Canada Goose and Veeva Systems highlight a renewed focus on fundamental strategy; it may be prudent to assess if the cited catalysts, such as product diversification and market share gains, are sustainable.